{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:38:33Z","timestamp":1774946313114,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"17","license":[{"start":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T00:00:00Z","timestamp":1432166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00253-015-6636-8","type":"journal-article","created":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T23:41:22Z","timestamp":1432078882000},"page":"7059-7068","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Production of canine adenovirus type 2 in serum-free suspension cultures of MDCK cells"],"prefix":"10.1007","volume":"99","author":[{"given":"R.","family":"Castro","sequence":"first","affiliation":[]},{"given":"P.","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"T.","family":"Laske","sequence":"additional","affiliation":[]},{"given":"M. F. Q.","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Y.","family":"Genzel","sequence":"additional","affiliation":[]},{"given":"K.","family":"Scharfenberg","sequence":"additional","affiliation":[]},{"given":"P. M.","family":"Alves","sequence":"additional","affiliation":[]},{"given":"A. S.","family":"Coroadinha","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,5,21]]},"reference":[{"key":"6636_CR1","first-page":"193","volume":"99","author":"N Altaras","year":"2005","unstructured":"Altaras N, Aunins JG, Evans RK, Kamen A, Konz JO, Wolf JJ (2005) Production and formulation of adenovirus vectors. Adv Biochem Eng Biotechnol 99:193\u2013260","journal-title":"Adv Biochem Eng Biotechnol"},{"issue":"3","key":"6636_CR2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/hum.2013.152","volume":"25","author":"L Ariza","year":"2014","unstructured":"Ariza L, Gim\u00e9nez-Llort L, Cubizolle A, Pag\u00e8s G, Garc\u00eda-Lareu B, Serratrice N, Cots D, Thwaite R, Chill\u00f3n M, Kremer EJ, Bosch A (2014) Central nervous system delivery of helper-dependent canine adenovirus corrects neuropathology and behavior in mucopolysaccharidosis type VII mice. Hum Gene Ther 25(3):199\u2013211","journal-title":"Hum Gene Ther"},{"issue":"1","key":"6636_CR3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/bit.22364","volume":"104","author":"V Bernal","year":"2009","unstructured":"Bernal V, Carinhas N, Yokomizo AY, Carrondo MJ, Alves PM (2009) Cell density effect in the baculovirus-insect cells system: a quantitative analysis of energetic metabolism. Biotechnol Bioeng 104(1):162\u2013180","journal-title":"Biotechnol Bioeng"},{"issue":"9","key":"6636_CR4","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.3390\/v2092134","volume":"2","author":"T Bru","year":"2010","unstructured":"Bru T, Salinas S, Kremer EJ (2010) An update on canine adenovirus type 2 and its vectors. Viruses 2(9):2134\u20132153","journal-title":"Viruses"},{"issue":"1","key":"6636_CR5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ymben.2009.08.008","volume":"12","author":"N Carinhas","year":"2010","unstructured":"Carinhas N, Bernal V, Monteiro F, Carrondo MJ, Oliveira R, Alves PM (2010) Improving baculovirus production at high cell density through manipulation of energy metabolism. Metab Eng 12(1):39\u201352","journal-title":"Metab Eng"},{"issue":"1\u20132","key":"6636_CR6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0141-0229(00)00151-4","volume":"27","author":"HJ Cruz","year":"2000","unstructured":"Cruz HJ, Freitas CM, Alves PM, Moreira JL, Carrondo MJ (2000) Effects of ammonia and lactate on growth, metabolism, and productivity of BHK cells. Enzyme Microb Technol 27(1\u20132):43\u201352","journal-title":"Enzyme Microb Technol"},{"issue":"4","key":"6636_CR7","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/mt.2013.283","volume":"22","author":"A Cubizolle","year":"2014","unstructured":"Cubizolle A, Serratrice N, Skander N, Colle MA, Ibanes S, Gennetier A, Bayo-Puxan N, Mazouni K, Mennechet F, Joussemet B, Cherel Y, Lajat Y, Vite C, Bernex F, Kalatzis V, Haskins ME, Kremer EJ (2014) Corrective GUSB transfer to the canine mucopolysaccharidosis VII brain. Mol Ther 22(4):762\u2013773","journal-title":"Mol Ther"},{"issue":"2","key":"6636_CR8","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1021\/bp0256768","volume":"19","author":"V Deparis","year":"2003","unstructured":"Deparis V, Jestin A, Marc A, Goergen JL (2003) Use of flow cytometry to monitor infection and recombinant human alpha-1,3\/4 fucosyltransferase production in baculovirus infected Sf9 cell cultures. Biotechnol Prog 19(2):624\u2013630","journal-title":"Biotechnol Prog"},{"issue":"6","key":"6636_CR9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1586\/erv.09.31","volume":"8","author":"A Doroshenko","year":"2009","unstructured":"Doroshenko A, Halperin SA (2009) Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines). Expert Rev Vaccines 8(6):679\u2013688","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"6636_CR10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.tiv.2005.09.006","volume":"20","author":"E Falkner","year":"2006","unstructured":"Falkner E, Appl H, Eder C, Losert UM, Schoffl H, Pfaller W (2006) Serum free cell culture: the free access online database. Toxicol In Vitro 20(3):395\u2013400","journal-title":"Toxicol In Vitro"},{"issue":"4","key":"6636_CR11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/gt.2012.52","volume":"20","author":"P Fernandes","year":"2013","unstructured":"Fernandes P, Peixoto C, Santiago VM, Kremer EJ, Coroadinha AS, Alves PM (2013a) Bioprocess development for canine adenovirus type 2 vectors. Gene Ther 20(4):353\u2013360","journal-title":"Gene Ther"},{"issue":"4","key":"6636_CR12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060342","volume":"8","author":"P Fernandes","year":"2013","unstructured":"Fernandes P, Santiago VM, Rodrigues AF, Tomas H, Kremer EJ, Alves PM, Coroadinha AS (2013b) Impact of E1 and Cre on adenovirus vector amplification: developing MDCK CAV-2-E1 and E1-Cre transcomplementing cell lines. PLoS One 8(4), e60342","journal-title":"PLoS One"},{"key":"6636_CR13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/btpr.64","volume":"25","author":"TB Ferreira","year":"2009","unstructured":"Ferreira TB, Perdigao R, Silva AC, Zhang C, Aunins JG, Carrondo MJ, Alves PM (2009) 293 cell cycle synchronisation adenovirus vector production. Biotechnol Prog 25:235\u2013243","journal-title":"Biotechnol Prog"},{"issue":"12","key":"6636_CR14","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1586\/erv.09.128","volume":"8","author":"Y Genzel","year":"2009","unstructured":"Genzel Y, Reichl U (2009) Continuous cell lines as a production system for influenza vaccines. Expert Rev Vaccines 8(12):1681\u20131692","journal-title":"Expert Rev Vaccines"},{"issue":"17\u201318","key":"6636_CR15","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.vaccine.2003.11.041","volume":"22","author":"Y Genzel","year":"2004","unstructured":"Genzel Y, Behrendt I, Konig S, Sann H, Reichl U (2004) Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture. Vaccine 22(17\u201318):2202\u20132208","journal-title":"Vaccine"},{"issue":"9","key":"6636_CR16","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/bit.260280912","volume":"28","author":"MW Glacken","year":"1986","unstructured":"Glacken MW, Fleischaker RJ, Sinskey AJ (1986) Reduction of waste product excretion via nutrient control: possible strategies for maximizing product and cell yields on serum in cultures of mammalian cells. Biotechnol Bioeng 28(9):1376\u20131389","journal-title":"Biotechnol Bioeng"},{"issue":"4","key":"6636_CR17","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.micinf.2005.11.007","volume":"8","author":"R Hu","year":"2006","unstructured":"Hu R, Zhang S, Fooks AR, Yuan H, Liu Y, Li H, Tu C, Xia X, Xiao Y (2006) Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein. Microbes Infect 8(4):1090\u20131097","journal-title":"Microbes Infect"},{"issue":"29","key":"6636_CR18","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1016\/j.vaccine.2007.05.024","volume":"25","author":"RL Hu","year":"2007","unstructured":"Hu RL, Liu Y, Zhang SF, Zhang F, Fooks AR (2007) Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies. Vaccine 25(29):5301\u20135307","journal-title":"Vaccine"},{"issue":"1","key":"6636_CR19","volume":"6","author":"AY Hu","year":"2011","unstructured":"Hu AY, Tseng YF, Weng TC, Liao CC, Wu J, Chou AH, Chao HJ, Gu A, Chen J, Lin SC et al (2011) Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium. PLoS One 6(1), e14578","journal-title":"PLoS One"},{"issue":"35","key":"6636_CR20","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1016\/j.vaccine.2012.05.065","volume":"30","author":"B Isken","year":"2012","unstructured":"Isken B, Genzel Y, Reichl U (2012) Productivity, apoptosis, and infection dynamics of influenza A\/PR\/8 strains and A\/PR\/8-based reassortants. Vaccine 30(35):5253\u20135261","journal-title":"Vaccine"},{"issue":"11","key":"6636_CR21","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1002\/bit.23215","volume":"108","author":"R Janke","year":"2011","unstructured":"Janke R, Genzel Y, Handel N, Wahl A, Reichl U (2011a) Metabolic adaptation of MDCK cells to different growth conditions: effects on catalytic activities of central metabolic enzymes. Biotechnol Bioeng 108(11):2691\u20132704","journal-title":"Biotechnol Bioeng"},{"issue":"Suppl 8","key":"6636_CR22","doi-asserted-by":"crossref","first-page":"P129","DOI":"10.1186\/1753-6561-5-S8-P129","volume":"5","author":"R Janke","year":"2011","unstructured":"Janke R, Genzel Y, Wetzel M, Reichl U (2011b) Effect of influenza virus infection on key metabolic enzyme activities in MDCK cells. BMC Proc 5(Suppl 8):P129","journal-title":"BMC Proc"},{"issue":"1","key":"6636_CR23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/JVI.74.1.505-512.2000","volume":"74","author":"EJ Kremer","year":"2000","unstructured":"Kremer EJ, Boutin S, Chillon M, Danos O (2000) Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer. J Virol 74(1):505\u2013512","journal-title":"J Virol"},{"issue":"Pt 12","key":"6636_CR24","first-page":"3201","volume":"86","author":"LP Le","year":"2005","unstructured":"Le LP, Li J, Ternovoi VV, Siegal GP, Curiel DT (2005) Fluorescently tagged canine adenovirus via modification with protein IX-enhanced green fluorescent protein. J Gen Virol 86(Pt 12):3201\u20133208","journal-title":"J Gen Virol"},{"issue":"42","key":"6636_CR25","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1016\/j.vaccine.2008.08.001","volume":"26","author":"Y Liu","year":"2008","unstructured":"Liu Y, Zhang S, Ma G, Zhang F, Hu R (2008) Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine. Vaccine 26(42):5368\u20135372","journal-title":"Vaccine"},{"issue":"46","key":"6636_CR26","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1016\/j.vaccine.2009.06.024","volume":"27","author":"J Liu","year":"2009","unstructured":"Liu J, Shi X, Schwartz R, Kemble G (2009) Use of MDCK cells for production of live attenuated influenza vaccine. Vaccine 27(46):6460\u20136463","journal-title":"Vaccine"},{"issue":"36","key":"6636_CR27","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1016\/j.vaccine.2009.05.083","volume":"27","author":"V Lohr","year":"2009","unstructured":"Lohr V, Rath A, Genzel Y, Jordan I, Sandig V, Reichl U (2009) New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation. Vaccine 27(36):4975\u20134982","journal-title":"Vaccine"},{"issue":"38","key":"6636_CR28","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1016\/j.vaccine.2010.07.004","volume":"28","author":"V Lohr","year":"2010","unstructured":"Lohr V, Genzel Y, Behrendt I, Scharfenberg K, Reichl U (2010) A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor. Vaccine 28(38):6256\u20136264","journal-title":"Vaccine"},{"issue":"1","key":"6636_CR29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/bit.20890","volume":"94","author":"L Maranga","year":"2006","unstructured":"Maranga L, Goochee CF (2006) Metabolism of PER.C6 cells cultivated under fed-batch conditions at low glucose and glutamine levels. Biotechnol Bioeng 94(1):139\u2013150","journal-title":"Biotechnol Bioeng"},{"key":"6636_CR30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4899-1382-1_19","volume":"397","author":"OW Merten","year":"1996","unstructured":"Merten OW, Hannoun C, Manuguerra JC, Ventre F, Petres S (1996) Production of influenza virus in cell cultures for vaccine preparation. Adv Exp Med Biol 397:141\u2013151","journal-title":"Adv Exp Med Biol"},{"issue":"7\u20138","key":"6636_CR31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0734-9750(02)00030-7","volume":"20","author":"I Nadeau","year":"2003","unstructured":"Nadeau I, Kamen A (2003) Production of adenovirus vector for gene therapy. Biotechnol Adv 20(7\u20138):475\u2013489","journal-title":"Biotechnol Adv"},{"issue":"3","key":"6636_CR32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1097-0320(19991101)37:3<238::AID-CYTO11>3.0.CO;2-9","volume":"37","author":"T Nordstrom","year":"1999","unstructured":"Nordstrom T, Willamo P, Arvela M, Stenroos K, Lindqvist C (1999) Detection of baculovirus-infected insect cells by flow cytometric side-scatter analyses. Cytometry 37(3):238\u2013242","journal-title":"Cytometry"},{"issue":"5","key":"6636_CR33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biologicals.2010.04.003","volume":"38","author":"D Onions","year":"2010","unstructured":"Onions D, Egan W, Jarrett R, Novicki D, Gregersen JP (2010) Validation of the safety of MDCK cells as a substrate for the production of a cell-derived influenza vaccine. Biologicals 38(5):544\u2013551","journal-title":"Biologicals"},{"issue":"11","key":"6636_CR34","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/sj.mt.6300289","volume":"15","author":"M Perreau","year":"2007","unstructured":"Perreau M, Gu\u00e9rin MC, Drouet C, Kremer EJ (2007) Interactions between human plasma components and a xenogenic adenovirus vector: reduced immunogenicity during gene transfer. Mol Ther 15(11):1998\u20132007","journal-title":"Mol Ther"},{"issue":"48","key":"6636_CR35","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1016\/j.vaccine.2013.09.051","volume":"31","author":"B Peschel","year":"2013","unstructured":"Peschel B, Frentzel S, Laske T, Genzel Y, Reichl U (2013) Comparison of influenza virus yields and apoptosis-induction in an adherent and a suspension MDCK cell line. Vaccine 31(48):5693\u20135699","journal-title":"Vaccine"},{"issue":"1","key":"6636_CR36","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1021\/bp070198s","volume":"24","author":"KS Sandhu","year":"2008","unstructured":"Sandhu KS, Al-Rubeai M (2008) Monitoring of the adenovirus production process by flow cytometry. Biotechnol Prog 24(1):250\u2013261","journal-title":"Biotechnol Prog"},{"issue":"3","key":"6636_CR37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0168-1656(95)00196-4","volume":"46","author":"M Schneider","year":"1996","unstructured":"Schneider M, Marison IW, von Stockar U (1996) The importance of ammonia in mammalian cell culture. J Biotechnol 46(3):161\u2013185","journal-title":"J Biotechnol"},{"issue":"1\u20133","key":"6636_CR38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1008021428969","volume":"28","author":"G Schoofs","year":"1998","unstructured":"Schoofs G, Monica TJ, Ayala J, Horwitz J, Montgomery T, Roth G, Castillo FJ (1998) A high-yielding serum-free, suspension cell culture process to manufacture recombinant adenoviral vectors for gene therapy. Cytotechnology 28(1\u20133):81\u201389","journal-title":"Cytotechnology"},{"issue":"1","key":"6636_CR39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jviromet.2009.09.010","volume":"163","author":"MM Segura","year":"2010","unstructured":"Segura MM, Monfar M, Puig M, Mennechet F, Ibanes S, Chillon M (2010) A real-time PCR assay for quantification of canine adenoviral vectors. J Virol Methods 163(1):129\u2013136","journal-title":"J Virol Methods"},{"issue":"6","key":"6636_CR40","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2174\/156652310793797694","volume":"10","author":"AC Silva","year":"2010","unstructured":"Silva AC, Peixoto C, Lucas T, Kuppers C, Cruz PE, Alves PM, Kochanek S (2010) Adenovirus vector production and purification. Curr Gene Ther 10(6):437\u2013455","journal-title":"Curr Gene Ther"},{"issue":"4","key":"6636_CR41","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1006\/mthe.2001.0263","volume":"3","author":"C Soudais","year":"2001","unstructured":"Soudais C, Boutin S, Kremer EJ (2001a) Characterization of cis-acting sequences involved in canine adenovirus packaging. Mol Ther 3(4):631\u2013640","journal-title":"Mol Ther"},{"issue":"12","key":"6636_CR42","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1096\/fj.01-0321fje","volume":"15","author":"C Soudais","year":"2001","unstructured":"Soudais C, Laplace-Builhe C, Kissa K, Kremer EJ (2001b) Preferential transduction of neurons by canine adenovirus vectors and their efficient retrograde transport in vivo. Faseb J 15(12):2283\u20132285","journal-title":"Faseb J"},{"issue":"8","key":"6636_CR43","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.vaccine.2013.11.044","volume":"32","author":"F Tapia","year":"2014","unstructured":"Tapia F, Vogel T, Genzel Y, Behrendt I, Hirschel M, Gangemi JD, Reichl U (2014) Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor. Vaccine 32(8):1003\u20131011","journal-title":"Vaccine"},{"issue":"1","key":"6636_CR44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jviromet.2010.09.029","volume":"171","author":"R Wielink van","year":"2011","unstructured":"van Wielink R, Kant-Eenbergen HC, Harmsen MM, Martens DE, Wijffels RH, Coco-Martin JM (2011) Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines. J Virol Methods 171(1):53\u201360","journal-title":"J Virol Methods"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-015-6636-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-015-6636-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-015-6636-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T05:07:16Z","timestamp":1566709636000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-015-6636-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,21]]},"references-count":44,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["6636"],"URL":"https:\/\/doi.org\/10.1007\/s00253-015-6636-8","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,21]]}}}